Exact Mass: 725.3344022

Exact Mass Matches: 725.3344022

Found 23 metabolites which its exact mass value is equals to given mass value 725.3344022, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

3-Formyl Rifamycin

26-formyl-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1^{4,7}.0^{5,28}]triaconta-1(28),2,4,9,19,21,25(29),26-octaen-13-yl acetate

C38H47NO13 (725.3047252)


   

PBD dimer

12-(3-{[5-(4-aminophenyl)-13-methoxy-2-oxo-3,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(14),4,8,10,12-pentaen-12-yl]oxy}propoxy)-13-methoxy-5-(4-methoxyphenyl)-3,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(14),4,8,10,12-pentaen-2-one

C42H39N5O7 (725.2849343999999)


   

2-Deacetylaustrotaxine

2-Deacetylaustrotaxine

C39H51NO12 (725.3411086)


   
   
   

7,9-O-diacetyltaxine A

7,9-O-diacetyltaxine A

C39H51NO12 (725.3411086)


   

14-O-acetyl-8-O-methyl-18-O-2-(2-methyl-4-oxo-4H-quinazoline-3-yl)benzoylcammaconine

14-O-acetyl-8-O-methyl-18-O-2-(2-methyl-4-oxo-4H-quinazoline-3-yl)benzoylcammaconine

C42H51N3O8 (725.3675966000001)


   

3-Formyl Rifamycin

3-formyl Rifamycin SV

C38H47NO13 (725.3047252)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D012294 - Rifamycins relative retention time with respect to 9-anthracene Carboxylic Acid is 1.493 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.492

   

3-Formylrifampin

3-Formyl Rifamycin

C38H47NO13 (725.3047252)


   

24-demethoxycarbonyl-24-methylstreptovaricin C

24-demethoxycarbonyl-24-methylstreptovaricin C

C39H51NO12 (725.3411086)


   

3,15,27-Triamino-7,19-dihydroxy-10,22,34-trimethyl-31-oxido-1,13,25-trioxa-7,19,31-triazacyclohexatriaconta-9,21,33-triene-2,8,14,20,26,32-hexone

3,15,27-Triamino-7,19-dihydroxy-10,22,34-trimethyl-31-oxido-1,13,25-trioxa-7,19,31-triazacyclohexatriaconta-9,21,33-triene-2,8,14,20,26,32-hexone

C33H53N6O12- (725.3721278)


   

[(9Z,19Z,21Z)-26-formyl-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate

[(9Z,19Z,21Z)-26-formyl-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate

C38H47NO13 (725.3047252)


   

(3S,3S,4R,6S,8R,8aR)-5-[2-(1-hydroxycycloheptyl)ethynyl]-6-[4-(2-hydroxyethoxy)phenyl]-1,2-dioxo-3,4-diphenyl-8-spiro[1H-indole-3,7-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]carboxamide

(3S,3S,4R,6S,8R,8aR)-5-[2-(1-hydroxycycloheptyl)ethynyl]-6-[4-(2-hydroxyethoxy)phenyl]-1,2-dioxo-3,4-diphenyl-8-spiro[1H-indole-3,7-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]carboxamide

C44H43N3O7 (725.3100847999999)


   

(3S,3S,4R,6S,8R,8aR)-5-[3-(carbamoylamino)prop-1-ynyl]-6-[4-(2-hydroxyethoxy)phenyl]-1,2-dioxo-3,4-diphenyl-N-prop-2-enyl-8-spiro[1H-indole-3,7-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]carboxamide

(3S,3S,4R,6S,8R,8aR)-5-[3-(carbamoylamino)prop-1-ynyl]-6-[4-(2-hydroxyethoxy)phenyl]-1,2-dioxo-3,4-diphenyl-N-prop-2-enyl-8-spiro[1H-indole-3,7-4,6,8,8a-tetrahydro-3H-pyrrolo[2,1-c][1,4]oxazine]carboxamide

C42H39N5O7 (725.2849343999999)


   
   
   
   
   
   
   
   

2-{[13-(4-hydroxy-5,6-dimethoxy-3-methylpyridin-2-yl)-3,5,11-trimethyltrideca-2,6,8,11-tetraen-4-yl]oxy}-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol

2-{[13-(4-hydroxy-5,6-dimethoxy-3-methylpyridin-2-yl)-3,5,11-trimethyltrideca-2,6,8,11-tetraen-4-yl]oxy}-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol

C36H55NO14 (725.362237)